RayzeBio, Inc. (RYZB) Misses Q3 EPS by 57c

RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform